Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$416K Sell
1,150
-50
-4% -$17.1K 0.21% 34
2026
Q1
$422K Sell
1,200
-50
-4% -$17.8K 0.23% 32
2025
Q4
$409K Hold
1,250
0.19% 33
2025
Q3
$353K Hold
1,250
0.17% 45
2025
Q2
$349K Hold
1,250
0.17% 45
2025
Q1
$389K Hold
1,250
0.21% 36
2024
Q4
$326K Sell
1,250
-36
-3% -$10.7K 0.16% 41
2024
Q3
$414K Buy
+1,286
New +$421K 0.2% 40
2022
Q2
Sell
-2,100
Closed -$508K 48
2022
Q1
$508K Hold
2,100
0.27% 33
2021
Q4
$472K Hold
2,100
0.25% 34
2021
Q3
$447K Hold
2,100
0.26% 33
2021
Q2
$512K Sell
2,100
-50
-2% -$12.3K 0.29% 30
2021
Q1
$535K Buy
2,150
+143
+7% +$34.1K 0.35% 27
2020
Q4
$461K Sell
2,007
-37
-2% -$8.53K 0.24% 32
2020
Q3
$520K Sell
2,044
-93
-4% -$23K 0.26% 35
2020
Q2
$504K Sell
2,137
-3,380
-61% -$771K 0.28% 31
2020
Q1
$1.12M Hold
5,517
0.67% 26
2019
Q4
$1.33M Buy
+5,517
New +$1.22M 0.78% 23

Other funds holding AMGN

Trust Company of Kansas's AMGN Position: Q2 2026 in Review

Trust Company of Kansas reduced its Amgen (AMGN) stake by 4.2% in Q2 2026, selling an estimated $17.1K and leaving 1,150 shares worth $416K. The position accounts for 0.21% of the portfolio, ranked #34.

Trust Company of Kansas first reported a position in AMGN in Q4 2019 and has held it in 18 quarters since. The position peaked at $1.33M in Q4 2019. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Trust Company of Kansas held 1,150 shares of Amgen worth $416K as of Q2 2026.
  • Trust Company of Kansas sold 50 Amgen shares in Q2 2026, an estimated $17.1K.
  • Amgen made up 0.21% of Trust Company of Kansas's portfolio in Q2 2026, its #34 holding.
  • Trust Company of Kansas first reported a position in Amgen in Q4 2019 and has held it in 18 quarters since.
  • Trust Company of Kansas's Amgen position peaked at $1.33M in Q4 2019.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Trust Company of Kansas's 13F filing for Q2 2026, filed 22 Jul 2026.